Latest Articles

Atherosclerotic Cardiovascular Disease Risk Assessment

Regulate LDL-C level for those undergoing coronary revascularization (Diabetic Patients)

Achievement of ESC/EAS LDL-C Treatment Goals After an ACS with Statin and Alirocumab

Clinical practice experience in patients with familial hypercholesterolemia (FH) from the Safeheart registry

Proprotein convertase subtilisin/kexin type 9 inhibitors for heterozygous familial hypercholesterolemia: A clinical practice experience from the Safeheart registry

Odyssey outcomes - total events results

Optimal use of LLT after ACS

Odyssey outcomes - PVD results

Odyssey Outcomes - PVD Sub-analysis

Real-life safety and efficacy of Alirocumab - Odyssey apprise study

Safety and efficacy of alirocumab in patients with Hypercholesterolemia and high cardiovascular risk in a real-life setting.